Teva Pharmaceutical Industries
TEVA
$16.76
Share price
0.96%
Change (1 day)
124.97%
Change (1 year)
Categories
Teva Pharmaceutical Industries (TEVA) - Total assets
Total assets on the balance sheet as of March 2024 : $42.77 B
According to Teva Pharmaceutical Industries's latest financial reports the company's total assets are $42.77 B. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Teva Pharmaceutical Industries - Total assets on balance sheet (from 2001 to 2024)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2023-12-31 | $43.47 B | -1.21% |
| 2022-12-31 | $44.01 B | -7.67% |
| 2021-12-31 | $47.66 B | -5.87% |
| 2020-12-31 | $50.64 B | -11.88% |
| 2019-12-31 | $57.47 B | -5.29% |
| 2018-12-31 | $60.68 B | -14.07% |
| 2017-12-31 | $70.61 B | -24.12% |
| 2016-12-31 | $93.05 B | 71.59% |
| 2015-12-31 | $54.23 B | 16.83% |
| 2014-12-31 | $46.42 B | -2.29% |
| 2013-12-31 | $47.50 B | -6.13% |
| 2012-12-31 | $50.60 B | 0.93% |
| 2011-12-31 | $50.14 B | 31.43% |
| 2010-12-31 | $38.15 B | 14.88% |
| 2009-12-31 | $33.21 B | 0.93% |
| 2008-12-31 | $32.90 B | 40.54% |
| 2007-12-31 | $23.41 B | 14.37% |
| 2006-12-31 | $20.47 B | 97.08% |
| 2005-12-31 | $10.38 B | 7.84% |
| 2004-12-31 | $9.63 B | 62.82% |
| 2003-12-31 | $5.91 B | 27.86% |
| 2002-12-31 | $4.62 B | 33.72% |
| 2001-12-31 | $3.46 B |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 Novartis NVS | $94.33 B | 120.55% | 🇨🇭 Switzerland |
 Pfizer PFE | $221.09 B | 416.90% | 🇺🇸 USA |
 Sanofi SNY | $139.81 B | 226.88% | 🇫🇷 France |
 Merck MRK | $105.84 B | 147.47% | 🇺🇸 USA |
 AstraZeneca AZN | $102.29 B | 139.15% | 🇬🇧 UK |
 GlaxoSmithKline GSK | $73.94 B | 72.87% | 🇬🇧 UK |
 Dr. Reddy's RDY | $4.47 B | -89.53% | 🇮🇳 India |